[Reactogenicity and immunological effectiveness of a chemical sorbed typhoid vaccine in combination with choleragen-anatoxin administered subcutaneously by jet injector]. 1984

K G Gapochko, and O V Emel'ianova, and S I Konovalov, and V B Mokrousov, and T S Ttiova

The article presents immunological data substantiating the combined immunization of humans with the mixture of choleragen toxoid and chemical adsorbed typhoid vaccine, introduced subcutaneously by means of a jet injector.

UI MeSH Term Description Entries
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D007277 Injections, Jet The injection of solutions into the skin by compressed air devices so that only the solution pierces the skin. Jet Injections,Injection, Jet,Jet Injection
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D008297 Male Males
D002772 Cholera Toxin An ENTEROTOXIN from VIBRIO CHOLERAE. It consists of two major protomers, the heavy (H) or A subunit and the B protomer which consists of 5 light (L) or B subunits. The catalytic A subunit is proteolytically cleaved into fragments A1 and A2. The A1 fragment is a MONO(ADP-RIBOSE) TRANSFERASE. The B protomer binds cholera toxin to intestinal epithelial cells and facilitates the uptake of the A1 fragment. The A1 catalyzed transfer of ADP-RIBOSE to the alpha subunits of heterotrimeric G PROTEINS activates the production of CYCLIC AMP. Increased levels of cyclic AMP are thought to modulate release of fluid and electrolytes from intestinal crypt cells. Cholera Toxin A,Cholera Toxin B,Cholera Toxin Protomer A,Cholera Toxin Protomer B,Cholera Toxin Subunit A,Cholera Toxin Subunit B,Choleragen,Choleragenoid,Cholera Enterotoxin CT,Cholera Exotoxin,Cholera Toxin A Subunit,Cholera Toxin B Subunit,Procholeragenoid,Enterotoxin CT, Cholera,Exotoxin, Cholera,Toxin A, Cholera,Toxin B, Cholera,Toxin, Cholera
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

K G Gapochko, and O V Emel'ianova, and S I Konovalov, and V B Mokrousov, and T S Ttiova
September 1976, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
K G Gapochko, and O V Emel'ianova, and S I Konovalov, and V B Mokrousov, and T S Ttiova
November 1962, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
K G Gapochko, and O V Emel'ianova, and S I Konovalov, and V B Mokrousov, and T S Ttiova
November 1983, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
K G Gapochko, and O V Emel'ianova, and S I Konovalov, and V B Mokrousov, and T S Ttiova
April 1964, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
K G Gapochko, and O V Emel'ianova, and S I Konovalov, and V B Mokrousov, and T S Ttiova
April 1984, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
K G Gapochko, and O V Emel'ianova, and S I Konovalov, and V B Mokrousov, and T S Ttiova
January 1977, Archives roumaines de pathologie experimentales et de microbiologie,
K G Gapochko, and O V Emel'ianova, and S I Konovalov, and V B Mokrousov, and T S Ttiova
February 1971, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
K G Gapochko, and O V Emel'ianova, and S I Konovalov, and V B Mokrousov, and T S Ttiova
January 2011, Revista cubana de medicina tropical,
Copied contents to your clipboard!